Global Parkinsons Disease Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI679700
- March 18, 2019
- Global
- 105 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Parkinsons Disease market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Parkinsons Disease market."
The global Parkinsons Disease market is valued at 4240 million US$ in 2018 is expected to reach 6810 million US$ by the end of 2025, growing at a CAGR of 6.1% during 2019-2025.
This report focuses on Parkinsons Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Parkinsons Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Teva
Novartis
GSK
AbbVie
Merck
Boehringer Ingelheim
Impax
Lundbeck
Sun Pharma
Wockhardt
UCB
Valeant Pharmaceuticals
Acadia
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Carbidopa/Levodopa
Dopamine Receptor Agonists
MAO-Inhibitors
Segment by Application
Hospitals
Clinics
Table of Contents
Executive Summary
1 Parkinson's Disease Market Overview
1.1 Product Overview and Scope of Parkinson's Disease
1.2 Parkinson's Disease Segment by Type
1.2.1 Global Parkinson's Disease Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Carbidopa/Levodopa
1.2.3 Dopamine Receptor Agonists
1.2.4 MAO-Inhibitors
1.3 Parkinson's Disease Segment by Application
1.3.1 Parkinson's Disease Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Parkinson's Disease Market by Region
1.4.1 Global Parkinson's Disease Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Parkinson's Disease Market Size
1.5.1 Global Parkinson's Disease Revenue (2014-2025)
1.5.2 Global Parkinson's Disease Production (2014-2025)
2 Global Parkinson's Disease Market Competition by Manufacturers
2.1 Global Parkinson's Disease Production Market Share by Manufacturers (2014-2019)
2.2 Global Parkinson's Disease Revenue Share by Manufacturers (2014-2019)
2.3 Global Parkinson's Disease Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Parkinson's Disease Production Sites, Area Served, Product Types
2.5 Parkinson's Disease Market Competitive Situation and Trends
2.5.1 Parkinson's Disease Market Concentration Rate
2.5.2 Parkinson's Disease Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Parkinson's Disease Production Market Share by Regions
3.1 Global Parkinson's Disease Production Market Share by Regions
3.2 Global Parkinson's Disease Revenue Market Share by Regions (2014-2019)
3.3 Global Parkinson's Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Parkinson's Disease Production
3.4.1 North America Parkinson's Disease Production Growth Rate (2014-2019)
3.4.2 North America Parkinson's Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Parkinson's Disease Production
3.5.1 Europe Parkinson's ...
| read more...
Related Reports
